Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 29.23 (-0.03%)
Omnicell: Q3 Earnings Snapshot

Omnicell: Q3 Earnings Snapshot

OMCL : 29.23 (-0.03%)
Omnicell: Q2 Earnings Snapshot

Omnicell: Q2 Earnings Snapshot

OMCL : 29.23 (-0.03%)
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO

/PRNewswire/ -- EmpiRx Health, the industry's only value-based PBM, today announced that the company's president, Danny Sanchez, has been named Chief Executive...

OMCL : 29.23 (-0.03%)
Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay

Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.

JNJ : 158.19 (+0.15%)
ISRG : 399.09 (-0.25%)
EW : 95.56 (+0.43%)
OMCL : 29.23 (-0.03%)
Omnicell to Present at the BofA Securities 2023 Healthcare Conference

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference...

OMCL : 29.23 (-0.03%)
Encompass Health's (EHC) Q1 Earnings Beat, '23 EPS View Up

Encompass Health's (EHC) Q1 results reflect improved patient volumes and higher discharge growth. Management estimates 2023 adjusted EPS within $2.94-$3.23, up from the earlier view of $2.87-$3.16.

OMCL : 29.23 (-0.03%)
IDXX : 539.93 (+0.07%)
ZBH : 131.98 (-0.48%)
EHC : 82.58 (+6.47%)
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Down

Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.

OMCL : 29.23 (-0.03%)
JNJ : 158.19 (+0.15%)
ISRG : 399.09 (-0.25%)
EW : 95.56 (+0.43%)
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 457.14% and 4.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

OMCL : 29.23 (-0.03%)
NVTA : 0.0195 (+2.63%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 29.23 (-0.03%)

Barchart Exclusives

What The USDA Prospective Plantings Report Means For Grains
Taking a look at the USDA Prospective Plantings report, what was surprising and why it opens the door to speculators reevaluating risk. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar